● AI Equity Research · Healthcare

Intuitive Surgical, Inc. (ISRG)

AI stock analysis · Medical Instruments & Supplies · Last analyzed Aug 18, 2026

Compass Score

3.0/5

Call

Hold

Price

$390.33

AI Target

$478.01 +22.5%

AI Analyst Summary

Intuitive Surgical's dominant position in robotic-assisted surgery — anchored by its da Vinci platform and expanding Ion bronchoscopy system — continues to drive compounding procedure volume growth, with EPS up 26.5% YoY and revenue growing 18.5%, both ahead of consensus expectations. The forward P/E of 32.3x and a PEG of 1.93 reflect a premium valuation that is broadly justified by ISRG's durable competitive moat, high switching costs, and a large underpenetrated global surgical addressable market. The key risk is valuation compression if procedure growth decelerates or hospital capital spending tightens amid macroeconomic pressure.

Catalysts

Da Vinci 5 system adoption ramp — new-generation platform launched in 2024 with enhanced capabilities; accelerating placements could meaningfully expand installed base and drive incremental instrument/accessory revenue through 2025.
Ion bronchoscopy system expansion — continued rollout into pulmonary procedures represents a high-growth adjacency that diversifies revenue beyond general surgery and gynecology, with early clinical data supporting strong adoption curves.
International market penetration — Europe and Asia-Pacific procedural volumes growing faster than the U.S., with regulatory clearances in key markets (Japan, China) acting as near-term volume unlock catalysts.

Fundamentals

Pe Trailing P/E 45.2x / Forward P/E 32.3x · 2.0/5

Trailing P/E of 45.2x is a meaningful premium to the broader healthcare sector median (~25x), though the forward P/E of 32.3x reflects anticipated earnings expansion. Valuation is rich but partially justified by durable growth; not egregious, but not cheap.

Peg PEG 1.93 · 3.0/5

PEG of 1.93 sits in the neutral range (1.0–2.0), indicating the market is paying a fair but not discounted price for ISRG's growth. Growth quality is high, but the ratio does not signal a compelling value entry.

Analyst Rating Buy consensus (1.8) · 4.0/5

Consensus rating of 1.8 on an inverted scale maps to a strong Buy. With 24 Buy, 8 Hold, and 1 Sell across 30 analysts, sentiment is broadly constructive and well-covered. Scores as a 4 given it falls in the 1.5–2.5 range.

Earnings Trend EPS growth +26.5% YoY; Revenue growth +18.5% YoY · 5.0/5

Earnings growth of 26.5% YoY exceeds the 25% threshold for a top score, and revenue growth of 18.5% reflects strong procedural volume and system placements. The trajectory is accelerating and broad-based across geographies.

Price Target Beat 4 of 4 quarters beat (last 4 quarters) · 3.0/5

A perfect 4-of-4 beat rate over the most recent four quarters is encouraging, but per scoring guidelines, 4 of 8 quarters maps to a score of 3. Only 4 quarters of data are available, capping the score at neutral despite the perfect recent record.

Management Strong execution; consistent EPS beats · 4.0/5

Management has demonstrated consistent execution with 4-for-4 recent EPS beats, strong double-digit revenue and earnings growth, and high analyst confidence (30 analysts covered, 24 Buys). Capital discipline and market expansion strategy appear well-regarded. Limited multi-year beat history prevents a score of 5.

● See the full picture

Get today's top-scored picks, ranked for you.

Compass screens thousands of stocks every morning and hands you a short list of high-conviction picks — scored, explained, and re-ranked to your risk profile.

Start free for 3 days →

No credit card. Then $9/month. Cancel anytime.

How Compass scores stocks

Compass pre-filters thousands of U.S. equities by fundamentals, then an AI analyst scores each finalist 1–5 across six measures — spanning valuation, growth, analyst sentiment, and management quality — into one composite score, refreshed every market morning. Browse all covered stocks →

Not financial advice. Compass is an analytical tool, not a registered investment adviser or broker-dealer. Scores and recommendations are generated by AI, may be inaccurate or out of date, and are not investment, financial, legal, or tax advice. Investing involves risk, including loss of principal. Do your own research and consult a licensed financial professional. About Compass.